These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 11592053

  • 41. Quantitative structure-activity relationship studies on cholecystokinin antagonists.
    Gupta SP.
    Curr Pharm Des; 2002; 8(2):111-24. PubMed ID: 11812253
    [Abstract] [Full Text] [Related]

  • 42. Combinatorial solid phase synthesis of multiply substituted 1,4-benzodiazepines and affinity studies on the CCK2 receptor (part 1).
    Lattmann E, Billington DC, Poyner DR, Arayarat P, Howitt SB, Lawrence S, Offel M.
    Drug Des Discov; 2002; 18(1):9-21. PubMed ID: 12375632
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. The role of the cholecystokinin-B/gastrin receptor transmembrane domains in determining affinity for subtype-selective ligands.
    Kopin AS, McBride EW, Quinn SM, Kolakowski LF, Beinborn M.
    J Biol Chem; 1995 Mar 10; 270(10):5019-23. PubMed ID: 7890609
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Cholecystokinins and their receptors. Functional aspects].
    Böhme GA, Blanchard JC.
    Therapie; 1992 Nov 10; 47(6):541-8. PubMed ID: 1301646
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonists.
    Low CM, Black JW, Broughton HB, Buck IM, Davies JM, Dunstone DJ, Hull RA, Kalindjian SB, McDonald IM, Pether MJ, Shankley NP, Steel KI.
    J Med Chem; 2000 Sep 21; 43(19):3505-17. PubMed ID: 11000005
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. On the biologically active structures of cholecystokinin, little gastrin, and enkephalin in the gastrointestinal system.
    Pincus MR, Carty RP, Chen J, Lubowsky J, Avitable M, Shah D, Scheraga HA, Murphy RB.
    Proc Natl Acad Sci U S A; 1987 Jul 21; 84(14):4821-5. PubMed ID: 3037525
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Unsulfated cholecystokinin: An overlooked hormone?
    Rehfeld JF, Agersnap M.
    Regul Pept; 2012 Jan 10; 173(1-3):1-5. PubMed ID: 21985915
    [Abstract] [Full Text] [Related]

  • 58. The seventh transmembrane domain of gastrin/CCK receptors contributes to non-peptide antagonist binding.
    Mantamadiotis T, Baldwin GS.
    Biochem Biophys Res Commun; 1994 Jun 30; 201(3):1382-9. PubMed ID: 8024583
    [Abstract] [Full Text] [Related]

  • 59. Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin.
    Kennedy K, Gigoux V, Escrieut C, Maigret B, Martinez J, Moroder L, Fréhel D, Gully D, Vaysse N, Fourmy D.
    J Biol Chem; 1997 Jan 31; 272(5):2920-6. PubMed ID: 9006937
    [Abstract] [Full Text] [Related]

  • 60. [Structure-activity relationship of cystokinins: analogs exhibiting selective activity].
    Martinez J, Rodriguez M, Lignon MF, Galas MC, Amblard M, Rolland M, Mendre C, Fulcrand P, Laur J, Bernad N.
    J Pharm Belg; 1991 Jan 31; 46(1):9-16. PubMed ID: 2051303
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.